Document Detail


Omeprazole and clopidogrel: Should clinicians be worried?
MedLine Citation:
PMID:  20124268     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The US Food and Drug Administration has issued a warning that omeprazole (Prilosec) reduces the antiplatelet activity of clopidogrel (Plavix) by about 50%. However, the warning is based largely on ex vivo data. Preliminary results from a randomized clinical trial revealed no effect on cardiovascular outcomes when omeprazole was given with clopidogrel. We recommend that physicians continue to prescribe a proton pump inhibitor for patients receiving dual antiplatelet therapy who are at risk of gastrointestinal bleeding or have an indication for use of a proton pump inhibitor.
Authors:
Jeremiah P Depta; Deepak L Bhatt
Related Documents :
12465868 - The fda recommendations on fish intake during pregnancy.
17502258 - Factors affecting decreasing radiation dose for mammography in north carolina after 200...
18806958 - Synergistic immunostimulating activity of pidotimod and red ginseng acidic polysacchari...
7401408 - An extension of pa principle to the potentiation of drug effects, and its application t...
18602678 - Rate-dependent effects of bupropion on nicotine self-administration and food-maintained...
17490948 - Genetic variation in life-history reaction norms in a marine fish.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Cleveland Clinic journal of medicine     Volume:  77     ISSN:  1939-2869     ISO Abbreviation:  Cleve Clin J Med     Publication Date:  2010 Feb 
Date Detail:
Created Date:  2010-02-03     Completed Date:  2010-05-04     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8703441     Medline TA:  Cleve Clin J Med     Country:  United States    
Other Details:
Languages:  eng     Pagination:  113-6     Citation Subset:  IM    
Affiliation:
Department of Internal Medicine, Medicine Institute, Cleveland Clinic, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Anti-Ulcer Agents / administration & dosage,  adverse effects*
Drug Interactions
Drug Therapy, Combination / adverse effects
Humans
Omeprazole / administration & dosage,  adverse effects*
Platelet Aggregation Inhibitors / administration & dosage,  adverse effects*
Ticlopidine / administration & dosage,  adverse effects,  analogs & derivatives*
Chemical
Reg. No./Substance:
0/Anti-Ulcer Agents; 0/Platelet Aggregation Inhibitors; 55142-85-3/Ticlopidine; 73590-58-6/Omeprazole; 90055-48-4/clopidogrel

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Controversies in non-ST-elevation acute coronary syndromes and percutaneous coronary interventions.
Next Document:  Preventing venous thromboembolism in long-term care residents: Cautious advice based on limited data...